• Where Quality is Paramount

  • Existing customer?

NEWS & EVENTS

Pharmacy News

Latest News – PSNC Main site
Pharmaceutical Services Negotiating Committee

Quality Payments: Updated gateway criteria report now available
The NHS Business Services Authority (NHSBSA) has updated its weekly gateway criteria report, allowing community pharmacy contractors to check whether they have been assessed, using national datasets, as meeting four of the five gateway criteria (Advanced Services, NHS website, Community Pharmacy Patient Questionnaire (CPPQ) and NHSmail) – due to cyber security reasons, the report does not...

Change of circumstance or ODS code for your pharmacy? Read our guide
PSNC has updated its guidance to support contractors whose pharmacies are due to have a change of location or ownership. Changes of circumstance such as new owners, relocations and closures are subject to regulatory requirements, but PSNC’s guide focuses on mitigating potential IT/Electronic Prescription Service (EPS) issues where such changes are planned. PSNC recommends that...

GPhC publishes a new enforcement policy for registered pharmacies
The General Pharmaceutical Council (GPhC) has published a new enforcement policy for registered pharmacies, which intends to drive continuous improvement in the quality of care patients receive when using a pharmacy. The policy is aimed at community pharmacy contractors, whether sole trader, a partnership of pharmacists or a body corporate such as a limited company. It...

An introduction to Primary Care Networks (March 2019)
This PSNC Briefing provides an explanation for community pharmacy teams of what Primary Care Networks (PCNs) are and their role in the NHS. It can be used by LPCs as an introductory briefing on PCNs for contractors, as part of local work to engage contractors and their team in the work of networks. PSNC Briefing...

Market-entry applications to move online
At present there are 30+ pharmacy forms available including applications for change of ownership, consolidation, relocation and new pharmacies. PCSE confirm that a new approach for pharmacy forms will see the replacement of multiple paper forms with one single online application, accessible via PCSE Online. The newly developed online form which will replace the 30+...

EMIS to join national roll-out of EPS CDs
EMIS plans to implement EPS Controlled Drugs (CDs) for all of their GP practices between Monday 25th March and Monday 8th April 2019. This follows the recent announcement that Vision and TPP have rolled out EPS CDs to their GP practices. Once the EMIS rollout commences, it will result in a further substantial increase in...

Quality Payments: 10,292 contractors now validated
The latest NHS Business Services Authority (NHSBSA) weekly gateway report shows that 10,292 community pharmacy contractors have now been validated as meeting the five gateway criteria of the Quality Payments Scheme. This means that 10,292 contractors have been validated that they: Are offering patients the opportunity to access at least one Advanced Service at their...

Quality Payments: Have you had an email about the WES gateway criterion?
Community pharmacy contractors who, prior to today, have not had confirmation that their pharmacy has been validated as meeting the Warranted Environment Specification (WES) gateway criterion should have received an email today from the NHS Business Services Authority (NHSBSA) to their premises-shared NHSmail account*. This email will state whether their pharmacy has now been assessed, in...

Quality Payments: Updated gateway criteria report now available
The NHS Business Services Authority (NHSBSA) has updated its weekly gateway criteria report, allowing community pharmacy contractors to check whether they have been assessed, using national datasets, as meeting four of the five gateway criteria (Advanced Services, NHS website, Community Pharmacy Patient Questionnaire (CPPQ) and NHSmail) – due to cyber security reasons, the report does not...

Reclassification of gabapentin and pregabalin as CDs from 1st April 2019 – update
Community pharmacy teams are reminded that from 1st April 2019, pregabalin and gabapentin will be reclassified as Schedule 3 Controlled Drugs (CDs). NHS England has published a guidance document providing information on changes to the law relating to the reclassification of the drugs gabapentin and pregabalin and a patient leaflet informing patients of the changes...

Feeds from PSNC

Global Pharmaceutical News

PharmaTimes: PharmaTimes Website RSS
PharmaTimes - The latest news in healthcare and life sciences - PharmaTimes Website RSS

FDA places partial hold on clinical trials of venetoclax for multiple myeloma
US regulators have placed a partial clinical hold on all trials assessing venetoclax for multiple myeloma after a higher than expected number of patient deaths.

Scientists develop osteoarthritis pain vaccine
Scientists have developed and tested a vaccine that they say could be used to treat chronic pain caused by osteoarthritis.

AZ’ Farxiga shows CV benefit in diabetes patients
New analysis of trial data highlight cardiovascular benefits of AstraZeneca’s diabetes drug Farxiga.

GW sells priority review voucher for $105m
GW Pharmaceuticals is selling its rare paediatric disease priority review voucher (PRV) for $105 million to Biohaven Pharmaceutical.

Setback for Allergy’s birch pollen immunotherapy
Shares in UK-based Allergy Therapeutics have taken a dive after the firm’s immunotherapy for birch pollen allergy failed to hit targets in a late-stage trial.

Groundbreaking study finds optimum dosage of IV iron for kidney patients
New iron-trial results have paved the way for improved haemodialysis treatment.

Lewy Body Society grants £1 million for dementia research
The Lewy Body Society has announced that the latest recipients of its grant programme will be University of Cambridge, Newcastle University and Imperial College London.

Molecular patterns could better predict breast cancer recurrence
A study has found that molecular patterns could better predict breast cancer recurrence.

CMA drops anti-competitive case against MSD
The CMA has closed its investigation into a suspected anti-competitive discount scheme by MSD, findings no grounds for action.

NHS ‘overwhelmed despite best efforts of staff’
NHS England has published NHS performance statistics for February, which show that the service is continuing to struggle under pressure.

EU regulators expand Praluent’s label
European regulators have approved a new indication for Regeneron and Sanofi’s Praluent, allowing its use to cut cardiovascular risk in adults with established atherosclerotic CV disease (ASCVD).

Bedrock makes Emily Howman head of scientific services

David Chiswell OBE becomes Avillion board member

Steve Broadhurst new creative director at 11 London

Uveal melanoma study announced
Researchers have announced a study to identify new treatments for uveal melanoma.

Feeds from PHARMATIMES

CPhl worldwide

Thame Laboratories will network among the industry’s key players

Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is the most cost effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.

Find out more: https://www.cphi.com/europe/

Have you got any questions about our products? We're here to help